Many respiratory viruses cause us to temporarily lose our sense of smell. But SARS-CoV-2 isn’t like those other viruses. Researchers are now exploring how it differs and whether patients recover.
Scanning through billions of chemicals to find a few potential drugs for treating COVID-19 requires computers that harness together thousands of processors.
The use of antihypertension medication during the coronavirus pandemic has been a subject of hot debate but people should be cautious about simple conclusions.
A continuous lock down is detrimental to Nigeria’s large population of people living below poverty lines, but lifting the restrictions without a proper plan is equally dangerous. Here’s what to do.
Antibodies that recognize and block SARS-CoV-2 infection have the potential to be powerful weapons. An infectious disease expert explains what antibodies are and how they could be used as a therapy.
Since the state’s first coronavirus case surfaced, trained case investigators have traced the contacts of every person who tested positive. Here’s what else South Carolina got right.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It’s based on a vaccine that was already in development for influenza, and has shown promise in animal studies.
Thinking of SARS-CoV-2 as an invisible enemy with an evil personality and humanlike motivations is a natural offshoot of the way people evolved to anthropomorphize so as not to overlook threats.
Drama on massive production and importation of HCQ/CQ throughout the world has once again served as a reminder that public policy must stand on solid scientific foundation.
You’re heading to your first post-COVID-19 dinner party. How many guests is too many? Are hugging and handshakes OK now? And most importantly, should you bring your own cutlery?
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
The US president has reignited controversy over the use of malaria drugs to guard against COVID-19. But there is little reliable evidence so far that this tactic is safe or effective.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand